Researchers suggest a theory for the evolution of HIV from SIV

A new study has shed light on how human immunodeficiency virus (HIV) may have evolved from the simian immunodeficiency virus (SIV) that originated in non-human primates.

Credit: science photo/Shutterstock.com

Until now, researchers have been unable to establish how SIV could have made the leap to humans, since we possess a protective mechanism that should stop such infections occurring.

This protection comes in the form of a protein called tetherin, which is present on the surface of infected cells andserves as a sticky pad that stops the cells from releasing nascent virus particles.

To counteract this defence mechanism, viruses have evolved their own arsenal of proteins. One example is a HIV accessory protein called Vpu, which targets tetherin and enables the virus particles to be released.

In the current study, an international team led by Kei Sato and Yoshio Koyanagi of Kyoto University investigated whether the evolution of Vpu could have helped SIV make the species jump from monkeys to humans.

As reported in the journal Cell Host and Microbe, the team used reverse genetics to engineer HIV strains that had different Vpu mutants. They then explored which function of Vpu was key to successful infection.

"We used an immunodeficient mouse model with a reconstituted human immune system, established through the transplantation of human blood-forming stem cells," explains Koyanagi. The model enabled the team to study both SIV and HIV.

Sato says Vpu can degrade tetherin by inhibiting cellular immune signaling pathways: "The Vpu variant responsible for downregulating tetherin was the most important property of Vpu for HIV."

The researchers also found that restoring tetherin to normal levels could suppress viral replication, suggesting that a certain number of tetherin molecules can counteract HIV.

Notably, SIV was unable to infect human blood cells effectively in the mouse model. However, when SIV Vpu was endowed with the anti-tetherin activity of HIV Vpu, SIV was able to infect the cells.

From an evolutionary standpoint, our study suggests that a gain-of-function ability in Vpu to overcome human tetherin allowed SIV to infect a new host: us."

Kei Sato, Kyoto University

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 17). Researchers suggest a theory for the evolution of HIV from SIV. News-Medical. Retrieved on November 25, 2024 from https://www.news-medical.net/news/20180405/Researchers-suggest-a-theory-for-the-evolution-of-HIV-from-SIV.aspx.

  • MLA

    Robertson, Sally. "Researchers suggest a theory for the evolution of HIV from SIV". News-Medical. 25 November 2024. <https://www.news-medical.net/news/20180405/Researchers-suggest-a-theory-for-the-evolution-of-HIV-from-SIV.aspx>.

  • Chicago

    Robertson, Sally. "Researchers suggest a theory for the evolution of HIV from SIV". News-Medical. https://www.news-medical.net/news/20180405/Researchers-suggest-a-theory-for-the-evolution-of-HIV-from-SIV.aspx. (accessed November 25, 2024).

  • Harvard

    Robertson, Sally. 2019. Researchers suggest a theory for the evolution of HIV from SIV. News-Medical, viewed 25 November 2024, https://www.news-medical.net/news/20180405/Researchers-suggest-a-theory-for-the-evolution-of-HIV-from-SIV.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus